News | Magnetic Resonance Imaging (MRI) | July 25, 2022

Combined MRI/neuromodulation/drug delivery system could revolutionize mental health and neurological therapy 

Gwangju Institute of Science and Technology researchers improve the scanning capability of magnetic particle imaging systems used for medical imaging.

July 25, 2022 —  For any drug to be successful in treating mental health or neurological problems, the medicine has to penetrate the blood-brain barrier (BBB). The BBB is caused by tight openings in the microscopic vessels of the brain which prevent harmful substances from entering the brain, but also keep most useful drugs out. For example, only 0.01% of the anti-Alzheimer therapeutic antibodies in plasma enter the brain.  Of those few drugs that can enter the brain, many cause affect unwanted targets to cause side effects (for example, dyskinesias or weight gain). In results published in the journal Pharmaceutics (https://www.mdpi.com/1999-4923/14/7/1503), Weinberg Medical Physics (WMP) has demonstrated the ability to open the blood-brain-barrier (BBB) in mice and to safely deliver drugs using pulsed magnetic fields with tailored waveforms.  This work, performed in collaboration with Georgetown University, spurs development of a new class of noninvasive image-guided devices capable of safely treating many mental health and neurological disorders. 

Funded by the National Institute for Aging grant aimed at curing Alzheimer disease, the authors demonstrated that a new type of MRI composed of electro-permanent magnets could be used to generate tailored electromagnetic waveforms, some of which were much more effective at opening the BBB than others. As in a CT scanner, the selective electromagnetic waveforms could be applied from multiple sources to focally deliver drugs to specific regions of the brain.  The same device could also use magnetic pulses to help regrow neurons (“plasticity”), as is being done with transcranial magnetic stimulation (TMS). According to Dr. Irving Weinberg, President of WMP, “This new device would allow psychiatrists and neurologists to treat diseased or underdeveloped brain tracts without causing unwanted side effects. Potential disorders to be treated could include addiction, autism, depression, neuropathic pain, and Alzheimer and Parkinson diseases.”  

Using an office-based human-sized version of this non-invasive device, it may prove possible to cure Alzheimer’s by delivering drugs and genes to specified tracts in the brain under real-time imaging guidance. 

For more information: https://www.weinbergmedicalphysics.com/ 


Related Content

News | Ultrasound Imaging

Sept. 2, 2026 – Sonex Health and The Institute of Advanced Ultrasound Guided Procedures have announced publication of ...

Time September 04, 2026
arrow
News | Radiation Oncology

Sept. 2, 2026 — Children with one of the deadliest forms of brain cancer may benefit from an additional course of ...

Time September 03, 2026
arrow
News | Radiology Imaging

Sept. 1, 2026— A new study from the Harvey L. Neiman Health Policy Institute found that the odds of imaging following an ...

Time September 01, 2026
arrow
News | Radiology Business

August 18, 2026 – NewVue, a provider of cloud-native software that unifies how radiologists work while improving ...

Time August 25, 2026
arrow
News | RSNA

Aug. 18, 2026 —The board of trustees of the Radiological Society of North America's (RSNA) Research & Education (R&E) ...

Time August 24, 2026
arrow
News | Radiology Imaging

Aug. 13, 2026 — Epic's new Care Everywhere Diagnostic Image Exchange allows health systems using Epic to share ...

Time August 21, 2026
arrow
News | Cardiac Imaging

Aug. 20, 2026 – The novel, radiopaque, polymer-based embolic coil from Embolization, Inc. has now surpassed 125 implants ...

Time August 20, 2026
arrow
Feature | Artificial Intelligence | Madhu Jahagirdar

Radiologists spend much of their day moving between different systems: One application to review images. Another to ...

Time August 17, 2026
arrow
News | X-Ray

Aug. 10, 2026 — Teledyne Technologies Inc. and Varex Imaging Corp. have jointly announced that they have entered into a ...

Time August 14, 2026
arrow
News | FDA

Aug. 1, 2026 — Candelis recently announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance ...

Time August 13, 2026
arrow
Subscribe Now